Relentless Curing Age-Related Diseases w Epigenetic Medicines | Lada Nuzhna, General Control
15 snips
Nov 20, 2025 
Lada Nuzhna, Founder and CEO of General Control, specializes in epigenetic therapies for age-related diseases. She shares her fascinating journey from physics to aging research, driven by a passion for extending healthy life. Lada discusses the transformative power of the epigenome and her innovative approach to disease-driving gene expression. With insights on funding, early human trials in China, and the challenges of aging research, she emphasizes the importance of agile biotech teams. Her personal story of growing up in Eastern Ukraine adds depth to her visionary ambitions in longevity.
AI Snips
Chapters
Transcript
Episode notes
Epigenome Is The Cell's Operating System
- The epigenome acts like the cell's operating system and determines cell identity and age.
- Epigenetic editing can permanently rewrite gene expression, offering curative potential beyond chronic drugs.
Speed Up Funding With Short Grants
- Simplify funding processes to accelerate bold academic ideas and reduce grant bureaucracy.
- Use short proposals and fast review cycles to unlock ambitious aging research quickly.
Target Programs, Not Single Proteins
- New therapeutic modalities aim to tackle multifactorial aging diseases by editing gene expression programs.
- Targeted epigenetic editors can permanently suppress pathological genes instead of lifelong drugs.